SPECIAL NOTICE
A -- Autonomous Pathogendetection System (APDS)
- Notice Date
- 3/14/2002
- Notice Type
- Special Notice
- Contracting Office
- Department of Energy, Lawrence Livermore National Laboratory (DOE Contractor), Industrial Partnerships & Commercialization, 7000 East Avenue L-795, Livermore, CA, 94550
- ZIP Code
- 94550
- Solicitation Number
- Reference-Number-FBO02-006-293
- Response Due
- 4/14/2002
- Archive Date
- 4/15/2002
- Point of Contact
- Connie Pitcock, Administration, Phone 925-422-1072, Fax 925-423-8988, - Helen Peck, Admin. Assistant, Phone 925-422-4211, Fax 925-423-8988,
- E-Mail Address
-
pitcock1@llnl.gov, peck11@llnl.gov
- Description
- LAWRENCE LIVERMORE NATIONAL LABORATORY SEEKS PARTNERSHIPS WITH INDUSTRY TO COMMERCIALIZE AUTONOMOUS PATHOGENDETECTION SYSTEM (APDS). Announcement: Lawrence Livermore National Laboratory (LLNL), operated by the University of California under contract with the U.S. Department of Energy (DOE), is seeking one or more industrial partners to commercialize LLNL's Autonomous Pathogen Detection System (APDS). Scientists at LLNL have invented a stand-alone system for rapid, continuous monitoring of multiple airborne biological threat agents in the environment. This system, the autonomous pathogen detection system (APDS), acts as a "biosmoke alarm" and is targeted for domestic applications in which the public is at high risk to exposure to covert releases of bioagent (such as mass transit, office complexes, and convention centers), and as part of a monitoring network for urban areas and major gatherings (inaugurations, Olympics, etc.). The APDS is completely automated, offering aerosol sampling, in-line sample preparation fluidics, multiplex flow cytometer detection and identification assays, and orthogonal, flow-through PCR (nucleic acid) amplification and detection. This system has several key advantages over competing technologies: (1) the ability to measure up to 100 different agents and controls in a single sample, (2) the flexibility and ease with which new bead-based assays can be developed and integrated into the system, (3) extremely low false positive and false negative detection due to the presence of two orthogonal detection methods, (4) the ability to use the same basic system components for multiple deployment architectures, and (5) the relatively low cost per assay and minimal consumables. LLNL is in the process of patenting this invention. In the meantime, LLNL is seeking industrial partners to commercialize the invention. LLNL is also looking for collaborative research and development to improve the invention and to explore other usages of the invention. Note: THIS IS NOT A PROCUREMENT. Companies interested in commercializing LLNL's Autonomous Pathogen Detection System (APDS) should provide a written statement of interest and a description of corporate capabilities relevant to commercializing the technology. Please provide your written statement within thirty (30) days from the date this announcement is printed to ensure consideration of your response. Written responses should be directed to: Lawrence Livermore National Laboratory Industrial Partnerships and Commercialization P.O. Box 808, L-795 Livermore, CA 94551-0808 Attn: FBO02-006-293
- Record
- SN00042481-W 20020316/020314213204 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |